Page last updated: 2024-09-02

tadalafil and Acute Myelogenous Leukemia

tadalafil has been researched along with Acute Myelogenous Leukemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Dirks, WG; Drexler, HG; Hu, L; Hu, Z; Wang, H; Wang, L; Wang, X; Wang, Y; Wang, Z; Xu, X; Yang, Y; Zhang, X; Zhao, Y	1

Other Studies

1 other study(ies) available for tadalafil and Acute Myelogenous Leukemia

Article	Year
Modulators of histone demethylase JMJD1C selectively target leukemic stem cells. FEBS open bio, 2021, Volume: 11, Issue:1 Topics: Antineoplastic Agents; Drug Screening Assays, Antitumor; Gene Expression Regulation, Leukemic; Homeodomain Proteins; Human Umbilical Vein Endothelial Cells; Humans; Jumonji Domain-Containing Histone Demethylases; Leukemia, Myeloid, Acute; Neoplastic Stem Cells; Oxidoreductases, N-Demethylating; Primary Cell Culture; Tadalafil	2021

Article

Year

Modulators of histone demethylase JMJD1C selectively target leukemic stem cells.

FEBS open bio, 2021, Volume: 11, Issue:1

Topics: Antineoplastic Agents; Drug Screening Assays, Antitumor; Gene Expression Regulation, Leukemic; Homeodomain Proteins; Human Umbilical Vein Endothelial Cells; Humans; Jumonji Domain-Containing Histone Demethylases; Leukemia, Myeloid, Acute; Neoplastic Stem Cells; Oxidoreductases, N-Demethylating; Primary Cell Culture; Tadalafil

2021